E-LIB Suche - Ergebnisse für: Petra Hyroššová

1

Effects of metabolic cancer therapy on tumor microenvironme..:

Hyroššová, Petra ; Milošević, Mirko ; Škoda, Josef...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

2

Glycosylation defects, offset by PEPCK-M, drive entosis in ..:

Hyroššová, Petra ; Aragó, Marc ; Muñoz-Pinedo, Cristina...
Cell Death & Disease. 13 (2022) 8 - p. , 2022

Link: https://doi.org/10.1038/..

3

Glycosylation defects, offset by PEPCK-M, drive entosis in ..:

Hyroššová, Petra ; Aragó, Marc ; Muñoz Pinedo, Cristina...
Reproducció del document publicat a: https://doi.org/10.1038/s41419-022-05177-x. , 2022

Link: http://hdl.handle.net/24..

4

Glycosylation defects, offset by PEPCK-M, drive entosis in ..:

Petra Hyroššová ; Marc Aragó ; Cristina Muñoz-Pinedo...
https://doi.org/10.1038/s41419-022-05177-x. , 2022

Link: https://doi.org/10.1038/..

5

Effects of metabolic cancer therapy on tumor microenvironme..:

Petra Hyroššová ; Mirko Milošević ; Josef Škoda...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1046630/full. , 2022

Link: https://doi.org/10.3389/..

6

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-de..:

Hyroššová, Petra ; Aragó, Marc ; Moreno-Felici, Juan...
Cancer & Metabolism. 9 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-de..:

Petra Hyroššová ; Marc Aragó ; Juan Moreno-Felici...
https://doi.org/10.1186/s40170-020-00236-3. , 2021

Link: https://doi.org/10.1186/..

8

PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-de..:

Hyroššová, Petra ; Aragó, Marc ; Moreno Felici, Juan...
Reproducció del document publicat a: https://doi.org/10.1186/s40170-020-00236-3. , 2021

Link: http://hdl.handle.net/24..

9

Pharmacology and preclinical validation of a novel anticanc..:

Aragó, Marc ; Moreno-Felici, Juan ; Abás, Sonia...
Biomedicine & Pharmacotherapy. 121 (2020) - p. 109601 , 2020

Link: https://doi.org/10.1016/..

10

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
EMBO Molecular Medicine. 12 (2020) 6 - p. , 2020

Link: https://doi.org/10.15252..

11

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
qt6bb8n8g5. , 2020

Link: https://escholarship.org..

12

Phosphoenolpyruvate from Glycolysis and PEPCK Regulate Canc..:

Moreno-Felici, Juan ; Hyrossová, Petra ; Aragó, Marc...
Reproducció del document publicat a: https://doi.org/10.3390/cells9010018. , 2020

Link: http://hdl.handle.net/24..

13

Tumors defective in homologous recombination rely on oxidat..:

Lahiguera, Álvaro ; Hyroššová, Petra ; Figueras, Agnès...
EMBO Molecular Medicine;12. , 2020

Link: https://hdl.handle.net/1..

14

Pharmacology and preclinical validation of a novel anticanc..:

Marc Aragó ; Juan Moreno-Felici ; Sonia Abás...
http://www.sciencedirect.com/science/article/pii/S0753332219352230. , 2020

Link: https://doi.org/10.1016/..

15

Pharmacology and preclinical validation of a novel anticanc..:

Aragó, Marc ; Moreno Felici, Juan ; Abás Prades, Sònia...
Reproducció del document publicat a: https://doi.org/10.1016/j.biopha.2019.109601. , 2020

Link: http://hdl.handle.net/24..